BACKGROUND Impulsive decision making is a hallmark of frequently occurring addictive disorders including alcohol dependence (AD). Therefore, ameliorating impulsive decision making is a promising target for the treatment of AD. Previous studies have shown that modafinil enhances cognitive control functions in various psychiatric disorders. However, the effects of modafinil on delay discounting and its underlying neural correlates have not been investigated as yet. The aim of the current study was to investigate the effects of modafinil on neural correlates of impulsive decision making in abstinent AD patients and healthy controls (HC).
INTRODUCTION
Impulsivity is a key feature of various psychiatric disorders, including highly prevalent addictive disorders such as alcohol dependence (Hasin et al. 2007 ). Impulsivity can be broadly defined as behavioral actions performed without adequate forethought and can be dissected into different independent domains (Evenden 1999) . Two widely recognized behavioral phenomena of impulsivity are 1) impulsive decision making, resulting from an increased preference for (smaller) immediate reward over larger but delayed reward (delay discounting) and 2) motor impulsivity, reflecting the failure to inhibit a prepotent but inappropriate response (Evenden 1999) . Alcohol dependent patients show impairments on both aspects of impulsivity (Bjork et al. 2004; Claus et al. 2011; Mitchell et al. 2005; Petry 2001; Takahashi et al. 2009 ) and especially impulsive decision making has been related to the persistence of drug abuse and relapse after a period of abstinence (Broos et al. 2012; Diergaarde et al. 2008; MacKillop and Kahler 2009; Stanger et al. 2011) . Therefore, ameliorating impulsive decision making could be an important target for the treatment of alcohol dependence.
One of the most promising compounds for the treatment of impulsive decision making is modafinil, a wakefulness-promoting drug approved for the treatment of narcolepsy and widely used as a cognitive enhancer (Greely et al. 2008; Joos et al. 2010; Sahakian and Morein-Zamir 2007) . In the field of addiction, modafinil was shown to reduce motor impulsivity in patients with methamphetamine dependence and pathological gambling (Dean et al. 2011; Zack and Poulos 2009) , and promising clinical effects have been reported in cocaine and methamphetamine dependence (Anderson et al. 2009; Hart et al. 2008; Shearer et al. 2009 ). However, the effects of modafinil on impulsive decision making in substance dependence have not been investigated as yet. There is only one study that has investigated the neural mechanisms by which modafinil improves cognitive functioning in substance dependent patients, showing that enhanced learning following a single dose of modafinil was associated with increased prefrontal activity in methamphetamine dependent patients (Ghahremani et al. 2011 ).
The current study therefore aimed to investigate the effects of a single dose of modafinil (200 mg) on impulsive decision making and its neural correlates in alcohol dependent patients compared to healthy volunteers using functional Magnetic Resonance Imaging (fMRI). A delay discounting task was employed to measure impulsive decision making. Delay discounting is a measure of impulsive decision making that is influenced by immediate reward contingencies and future outcomes and describes the relationship between the delay of a reward and its perceived value (Ainslie 1975) . Greater impulsivity is defined as a preference for smaller immediate rewards over larger delayed rewards. Recent studies in healthy volunteers have provided a better understanding of the neural substrates 137| underlying delay discounting. Specifically, dorsolateral prefrontal cortex (DLPFC, including the superior and middle frontal gyrus) in addition to parietal brain regions appear to be involved in cognitive control during intertemporal choices, the anterior cingulate cortex (ACC) is activated in response to decision conflict and the ventral striatum, ventromedial prefrontal cortex (vmPFC) and posterior cingulate cortex (PCC) track the subjective value of rewards (Bickel et al. 2009; Kable and Glimcher 2007; Marco-Pallares et al. 2010; McClure et al. 2004; Sripada et al. 2011; Wittmann et al. 2007) . Although some researchers have suggested that there are separate valuation systems for immediate and delayed rewards in which the value of delayed rewards is coded in frontoparietal regions and the value of immediate rewards in the ventral striatum, vmPFC and PCC (McClure et al. 2004) , there are also studies indicating that activity in these latter regions represents the subjective value of rewards at all delays (Kable and Glimcher 2007; Kable and Glimcher 2010) . With regard to substance dependence, altered recruitment of frontoparietal regions during delay discounting has been observed in methamphetamine and cocaine dependent patients compared to healthy controls (Meade et al. 2011; Monterosso et al. 2007 ) and increased activation of these frontoparietal regions has been associated with delayed gratification in methamphetamine and alcohol dependent patients (Claus et al. 2011; Hoffman et al. 2008) . Based on these neuroimaging findings, the current study examined the extent to which modafinil induces changes in brain activation in and connectivity between regions relevant for delay discounting. We hypothesized that modafinil will reduce delay discounting accompanied by normalized activation and connectivity of brain regions known to be involved in cognitive control (lateral PFC, lateral parietal cortex), conflict monitoring (ACC) and valuation of reward (ventral striatum, vmPFC, PCC).
METHODS

Subjects
Twenty male subjects meeting DSM-IV (American Psychiatry Association 1994) criteria for alcohol dependence (AD group) were recruited from regional addiction treatment centers. In addition, 18 healthy controls (HC group), matched on sex, education, and age were included. Exclusion criteria can be found in the Supplemental Methods. Six AD were excluded from all analyses due to scanner artefacts or positive urine tests on alcohol or drugs. Overall, data from 32 participants (14 AD, 18 HC) were included in our statistical analyses. All subjects gave written informed consent to participate in this study, which was approved by the Medical Ethical Committee of the Academic Medical Center of the University of Amsterdam.
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Design
We used a randomized double-blind placebo-controlled within-subjects cross-over design. Each subject participated in two sessions separated by one week. In the first session, subjects either received modafinil (200 mg) or placebo tablets. In the second session, subjects were crossed-over to receive the opposite study medication. The study medication was administered two hours before scanning, because peak plasma levels of modafinil occur at 2-4 hours after a single dose (Robertson and Hellriegel 2003) . Eight AD subjects and 9 HC subjects received modafinil in the first session and placebo in the second session.
Clinical assessments
All subjects were screened for the presence of Axis-I psychiatric disorders using the Mini International Neuropsychiatric Interview (MINI-plus; Sheehan et al. 1998) . Education level was classified into one of seven categories according to the International Standard Classification of Educational Degrees (ISCED; United Nations Educational Scientific and Cultural Organization (UNESCO) 1997). Subjects reported their level of income by selecting one of three categories (low, middle or high) of net income per month. The premorbid intelligence quotient (IQ) was assessed using the Dutch version of the National Adult Reading Test (NART; Schmand et al. 1991) . Alcohol and drug consumption during the preceding 6 months was quantified using the Time Line Follow Back method (TLFB; Sobell and Sobell 1992). In addition, the Alcohol Use Disorder Identification Test (AUDIT) was used to identify harmful patterns of alcohol consumption (Babor et al. 1989 ). The Short Alcohol Withdrawal Scale, a 10-item self-report questionnaire to measure alcohol withdrawal symptoms (with a total score ranging from 0-30) was administered before each session (Gossop et al. 2002) . To investigate modafinil-induced neurophysiologic side effects, a checklist assessing 15 possible side effects and potential stimulant effects of modafinil was used including symptoms such as headache, palpitations, nervousness, nausea, sweating and a dry mouth. Subjects were asked to rate these side effects on a scale from 0 (not at all) to 4 (severely). Craving was assessed using the Alcohol Urge Questionnaire (AUQ; Bohn et al. 1995) .
Delay Discounting Task
A delay discounting task (DDT; Wittmann et al. 2007 ) was used to assess impulsive decision making reflected by an increased preference for (smaller) immediate rewards over (larger) delayed rewards. Subjects were asked to make a decision between a hypothetical immediate reward and a reward to be received in the future. The task consisted of six blocks of eight preference judgment trials. Each block had a specific delay (5, 30, 180, 365, 1095, 3650 days) and an associated reward magnitude between 476 and 524 euro. Within each block, the future reward was fixed, whereas immediate reward magnitude was varied from trial to trial by successively narrowing the range according to a specific 139| rule. This resulted in an indifference point for every block, at which the immediate and delayed rewards were equally preferred. For a detailed description of the algorithm that was used to obtain the indifference points, see Wittmann et al. (2007) . By plotting the indifference points against each of the six delays, an estimation of the steepness of delay discounting could be obtained using the area-under-the-curve (AUC) method (Myerson et al. 2001) . Smaller AUC values represent steeper discounting rates and thus higher impulsive decision making.
Imaging Protocol
Magnetic Resonance Imaging data were obtained using a 3.0T Intera MRI scanner (Philips Healthcare, Best, The Netherlands) equipped with a SENSE eight-channel receiver head coil. A gradient-echo echo-planar (EPI) sequence sensitive to blood oxygenation level-dependent (BOLD) contrast (TR/TE=2300ms/25ms, matrix size 64x64, voxel size 2.29x2.29x3mm, 38 slices, no gap) was used to acquire approximately 240 images. Three-dimensional T1-weighted images were collected using a gradient echo sequence (TR=9ms; TE=3.5ms; 170 slices; voxel size 1x1x1mm; matrix size 256x256) for anatomical reference with the EPI data.
Data Analysis
Behavioral Data Demographic, self-report (side effects, craving) and DDT performance (AUC) data were analyzed using the Statistical Package for the Social Sciences version 16 (SPSS Inc., Chicago, IL, USA). Differences in baseline characteristics between groups were analysed using independent t-tests. A repeated measures ANOVA was conducted to assess self-reported effects of modafinil and DDT performance with treatment (modafinil versus placebo) modelled as a within-subject factor and group (AD vs. HC) as a between-subjects factor, including session order as a covariate. Income differed significantly between the groups (Table 1) . We included income (low, middle, high) as a covariate in the analyses because delay discounting may be affected by income (Bickel et al. 2010; Green et al. 1996; Kirby et al. 2002; Reimers et al. 2009 ). The significance level was set to p<0.05.
Imaging data
Imaging data were analyzed using Statistical Parametric Mapping (SPM8; Wellcome Trust Centre for Neuroimaging, London, UK). Functional images of each subject were realigned and unwarped, co-registered with the structural MRI image and segmented for normalization to an MNI template. Finally, images were smoothed using an 8mm full width at half maximum Gaussian kernel. Two main types of trial outcome were distinguished for each session: trials in which subjects selected the immediate reward and trials in which the subjects selected the delayed reward. In a first-level fixed-effects analysis, a statistical analytical design was constructed for each individual subject using general linear model (GLM) with the onset of the presentation of the trial, i.e. the display of the |140 delayed and immediate reward options, until the subject made a response, convolved with a canonical hemodynamic response function (HRF). Subject-specific regressors were separately generated for 1) selecting the immediate option (immediate choices) and 2) selecting the delayed option (delayed choices). To account for low-frequency signal drift a high-pass filter (1/128 Hz) was applied. Contrast images for immediate choices and delayed choices relative to an implicit baseline were computed for each session. These contrast images were then entered into a second-level random-effects analysis using a full factorial design with treatment (placebo, modafinil) and condition (immediate choices, delayed choices) modelled as within-subject factors and group (AD vs HC) as a between-subjects factor, including session order and income as covariates, to investigate within-group effects of treatment and group by treatment interaction effects. Independent t-tests, including covariates, were used to compare between-group effects on placebo and modafinil. We used MarsBaR (Brett et al. 2002) to calculate the effect size of activity change within the regions obtained by these second-level analyses. The effect size measures were correlated with changes (modafinil>placebo) in AUC values in order to investigate the association between changes in brain activation and changes in behavioral performance. To assess functional connectivity between brain regions associated with task performance that interacted with modafinil administration, we used a generalized form of Psychophysiological Interaction analyses (gPPI; McLaren et al. 2012 ), see Supplemental Methods for details of the analysis.
We focused our imaging analyses on a priori regions of interest (ROIs), which have consistently been reported in previous neuroimaging studies using delay discounting paradigms (Bickel et al. 2009; Kable and Glimcher 2007; Marco-Pallares et al. 2010; McClure et al. 2004; Sripada et al. 2011; Wittmann et al. 2007 ). These ROIs encompassed the lateral PFC consisting of the superior frontal gyrus and middle frontal gyrus, the lateral parietal lobe, the ACC extending to the SMA, the vmPFC, the PCC and the ventral striatum. The six ROIs were selected from the Nielsen and Hansen's volumes-of-interest defined in the Brainmap database (Nielsen and Hansen 2002) . Statistical tests had to meet p<0.05, family-wise error (FWE) voxel wise corrected for the spatial extent of the region of interest (ROI) by using small volume correction as implemented in SPM (Worsley et al. 1996) , to be considered significant, unless indicated otherwise. For non-hypothesized regions a whole-brain threshold of p<0.05, Family-wise Error (FWE) corrected, was applied.
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RESULTS
Demographics and clinical assessments
Demographic, self-report and substance use characteristics are presented in Table 1 . The AD group did not differ from the HC group with regard to age, educational level or IQ. AD subjects smoked significantly more cigarettes than HC subjects. We did not include smoking as a covariate in subsequent analyses, because smoking behavior was related to alcohol consumption during the past six months (r=0.53, p=0.05) and AUDIT scores (r=0.47, p=0.09). Therefore, including smoking as a covariate could also remove variance explained by problematic drinking. However, we did investigate whether there was a relation between delay discounting behavior and number of cigarettes smoked, but no significant correlation between AUC values and number of cigarettes smoked was found (r=-0.09, p=0.63). Income also differed significantly between the groups (Table 1) . Level of income was not associated with alcohol consumption in the last six months (F(13)=0.59, p=0.57) and AUDIT scores (F(13)=0.15, p=0.86), and was therefore included as a covariate in further analyses. No serious adverse events were reported and self-reported withdrawal symptoms before the fMRI sessions were mild to absent (all below 10 on a scale from 0-30). Modafinil administration did not increase the number of side effects compared to the placebo condition. With regard to self-reported craving, we found a significant group by treatment interaction effect (F(1,28)=4.53, p=0.04), which was driven by a significant reduction in craving in the AD group after modafinil administration (F(1,12)=10.58, p<0.01), see Table  2 . Figure 1 and Table 2 ). Post-hoc tests revealed that this effect was driven by a significant decrease in delay discounting behavior in the AD group (F(1,8)=9.3, p=0.02), whereas modafinil had no effect in the HC group (F(1,12)=0.01, Post-hoc tests revealed that this effect was driven by a significant increase in AUC values (i.e. reduced delay discounting) in the AD group, whereas modafinil had no effect in the HC group.
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Regional Brain Activations Main effect of task
Main effects of task across sessions and groups for immediate and delayed choices are presented in Table S1 and Figure S1 in the Supplemental Results. Replicating previous studies, areas of executive functioning (i.e. dorsolateral and inferior prefrontal cortex and parietal cortex), conflict monitoring (anterior cingulate cortex), limbic areas (striatum and thalamus) in addition to visual processing areas and middle temporal gyrus were activated during both the selection of the immediate and delayed reward option. In addition, the ventral medial prefrontal (vmPFC), posterior cingulate cortex (PCC), orbitofrontal cortex and lingual gyrus showed deactivation during the task. No significant differences in brain activation were found between immediate and delayed choices. Therefore, modafinil effects and group effects (AD vs. HC on placebo and modafinil) were examined separately for immediate and delayed choices instead of immediate>delayed choices and vice versa.
Brain activation differences between groups
Between the groups, we did not observe significant differences in the placebo or modafinil condition at our a priori threshold. At a slightly more liberal threshold of p<0.001 uncorrected, masked with our a priori defined ROIs to reduce the number of voxel-wise tests and hence the risk of Type I error, we found less activation in the left SFG (BA6) in AD subjects compared to HC subjects when selecting the immediate reward in the placebo |144 condition. When selecting the delayed reward in the placebo condition, AD also showed less activation in the left SFG (BA6) and more activation in the left PCC compared to HC. In the modafinil condition, there were no differences in brain activation between AD and HC with regard to both immediate and delayed choices.
Modafinil-induced brain activation changes within groups
In AD, comparing immediate choices in the modafinil condition to the placebo condition showed a significant increase in activation in the left superior frontal gyrus (SFG; rostral dorsolateral portion of BA6) and a left lateral parietal region (LPC) as shown in Figure 2 . In addition, a significant modafinil-induced decrease in activation was found in the right vmPFC (BA10). Comparing delayed choices in the modafinil condition to the placebo condition showed no differences in brain activation. In HC, no differences in brain activation between the modafinil and placebo conditions were found for immediate or the delayed choices.
For the AD group, we extracted the effect size of activity changes after modafinil administration during immediate choices (left SFG, left LPC and right vmPFC) to examine the correlation with the observed modafinil-induced changes in behavioral performance.
No correlations between these modafinil-induced activity changes and reduction in discounting behavior (AUC values) were found.
Changes in functional connectivity
To examine whether modafinil-induced changes in functional connectivity of the SFG (BA6), LPC and vmPFC with other brain regions during immediate choices were associated with the observed reduction in impulsive decision making (AUC values) in AD, PPI analyses were performed with the left SFG, left LPC and right vmPFC defined as seed regions by creating a 5mm sphere centered at the peak voxel coordinates 64; 37; 62, 10) . We regressed the AD subjects' PPI contrast images (immediate choices: modafinil>placebo) against their modafinil-induced changes in AUC values, including session order and income as covariates of no interest. For the LPC and vmPFC, we found no alterations in functional connectivity that were associated with changes in discounting behavior. For the SFG, there was a significant positive correlation between connectivity strength of the SFG with the left ventral striatum extending into the putamen and changes in AUC values (Figure 3 ), indicating that modafinil-induced reductions in delay discounting are accompanied by increased functional coupling of the left SFG with the left ventral striatum.
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Figure 2: Differences in neural activity between modafinil and placebo conditions during choices for immediate rewards in the AD group (statistical parametric maps and effect sizes at the peak voxels). Activity in regions displayed in red (left SFG and parietal region) significantly increased after modafinil administration. Activity in the vmPFC in blue significantly decreased after modafinil administration. The color bar represents voxel T value. |146
DISCUSSION
Our findings demonstrate beneficial effects of a single dose of modafinil on impulsive decision making and craving in alcohol dependent patients. These beneficial effects were accompanied by an enhanced recruitment of regions known to be involved in cognitive control (left SFG/BA6 and left lateral parietal cortex) and decreased engagement of a region involved in tracking the subjective value of rewards (vmPFC) during choices for immediate rewards. In addition, the observed modafinil-induced decrease in delay discounting was specifically associated with an increased functional coupling between the left SFG and left ventral striatum.
The rostral dorsolateral portion of Brodmann area 6 including the SFG is part of the premotor cortex which is not only important in planning and execution of movements but is also active in cognitive tasks that do not involve any immediate overt movement (Abe et al. 2007; Hanakawa et al. 2002) . This part of the left BA6 is largely connected to the dorsolateral PFC (Luppino et al. 2003 ) and known to be involved in higher-order cognitive functions including future envisioning (Szpunar et al. 2007 ), reasoning (Golde et al. 2010) , regulation of perceptual conflict (Kim et al. 2012 ) and complex mental calculations (Zago et al. 2001) . One may argue that these cognitive processes are all important for overruling short-sighted choices and consequently the ability to delay gratification. Indeed, neuroimaging studies examining delay discounting have implicated lateral prefrontal areas (McClure et al. 2004; Monterosso et al. 2007 ). In addition, we observed increased activation in the left lateral parietal cortex in AD after modafinil administration. Activation in these frontoparietal regions has been suggested to reflect biasing behavior towards choosing the larger later reward rather than the smaller and sooner reward (McClure et al. 2004 ). Abnormalities of frontoparietal recruitment have been observed in substance dependence during delay discounting, including alcohol dependence (Claus et al. 2011 ), cocaine dependence (Meade et al. 2011 ) and methamphetamine dependence (Hoffman et al. 2008; Monterosso et al. 2007 ). The current findings suggest that modafinil normalizes frontoparietal engagement during delay discounting in alcohol dependent patients, thereby possibly increasing cognitive control. Modafinil also reduced activation in the vmPFC in AD, an area associated with the subjective valuation of reward (Kable and Glimcher 2007; McClure et al. 2004 ) in addition to self-referential processes as part of the "default mode network" of the brain (for a review see Buckner et al. 2008) . The vmPFC has repeatedly been shown to correlate with steeper discounting of delayed rewards (see for example Kable and Glimcher 2010; Mitchell et al. 2011; Sripada et al. 2011) . Reduced activation during immediate choices in the modafinil condition could indicate that AD patients were less engaged in self-referential processes needed to valuate the immediate reward, whereas this area responded more strongly to the temptation of an instantaneous reward in the placebo condition.
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The modafinil-induced reduction in vmPFC activation and enhanced activation of the dorsolateral BA6 and lateral parietal cortex during immediate choices were not directly associated with the observed improvements in behavioral indices of delay discounting. However, an increased functional coupling between the left dorsolateral BA6 and the ventral striatum was related to the increased ability to delay gratification by modafinil in AD. Therefore it appears that modafinil exerts its impulsivity reducing effects in AD through enhancing connectivity between brain circuits instead of merely altering recruitment of individual brain regions. Anatomically, the striatum receives afferent (input) fibers from the rostral dorsolateral part of BA6 (Calzavara et al. 2007; Tachibana et al. 2004) , which mainly release excitatory neurotransmitters such as glutamate. Previous work has indeed indicated that modafinil elevates glutamate release in the striatum (Ferraro et al. 1998) and glutamine synthetase in frontoparietal regions (Touret et al. 1994) in rats. In addition, modafinil has been shown to impact monoamine signalling both in the prefrontal cortex (de Saint Hilaire et al. 2001; Ferraro et al. 2012 ) and the striatum (Spencer et al. 2010; Volkow et al. 2009 ). The observation of widespread effects of modafinil on brain circuits seems to match the effects of modafinil on a broad range of neurotransmitters in the brain, such as dopamine, noradrenaline, glutamate, serotonin and GABA (Minzenberg and Carter 2008) .
Of note, modafinil-induced changes in brain activation and connectivity were only observed during the selection of the immediate reward option. Enhanced SFG activation and SFG-ventral striatum connectivity in addition to decreased vmPFC activation during immediate choices by modafinil administration could reflect a more rational/deliberate instead of an impulsive decision when choosing the immediate reward, subsequently leading to an overall reduction in delay discounting. A study of Wittmann et al. (2010) indicated that ventral striatal activity is specifically associated with choosing the immediate reward and not the delayed reward, which might explain the currently observed increased prefrontal coupling with the ventral striatum only during immediate choices. However, whether separate neural systems are involved in the valuation of immediate and delayed rewards remains a topic of debate.
No effects of modafinil on both behavioral and neural indices of delay discounting were found in HC. These findings are consistent with previous observations that modafinil exerts its effects primarily in individuals that show poor initial performance on cognitive tasks (Finke et al. 2010; Hunter et al. 2006; Kalechstein et al. 2010; Spence et al. 2005) , probably also indicating that there was minimal room for improvement in the HC group. Modafinil was found to significantly reduce self-reported craving in AD, which is consistent with a previous clinical trial with modafinil in cocaine dependent patients (Anderson et al. 2009 ). Together with the reduction in impulsive decision making, these data suggest that modafinil could be an effective treatment for alcohol dependence. However, the current |148 study was not tailored to investigate (long-term) modafinil effects on clinical outcome because only a single dose was administered and therefore future clinical trials are warranted to further investigate modafinil effects on clinical outcome in AD.
It is important to stress that our results should be viewed in light of some limitations. First, the groups were not adequately matched on smoking behavior. We decided not to include smoking behavior as a covariate because of its high association with alcohol-related problems and the risk of overcorrection resulting in a serious reduction of the variance in problematic drinking. However, we did show that behavioral performance was not associated with smoking behavior. In addition, at baseline (placebo) no significant differences in delay discounting (AUC) were found between AD and HC, although AD displayed nominally smaller AUC values than HC, which may be explained by the relatively small sample size. Likewise, although modafinil induced robust changes in SFG activity as well as SFG-subcortical connectivity in AD, baseline SFG differences between groups were only evident at a slightly lower threshold, which is probably also due to limited power.
Taken together, the current study provides new insights into the neural correlates of the effect of modafinil on impulsive decision making. Moreover, our results indicate that modafinil can improve impulsive decision making, which is important for the treatment of alcohol dependence since the inability to delay gratification has been shown to predict relapse into substance abuse (MacKillop and Kahler 2009; Stanger et al. 2011 ). Boosting impulse control may help patients to resist the immediate rewarding properties of drinking alcohol and to take future negative consequences of alcohol use more into account. Modafinil may therefore constitute a useful adjunct in the treatment of alcohol dependence.
SUPPLEMENTAL MATERIAL Supplementary Methods
Exclusion criteria for participation Exclusion criteria were: current DSM-IV diagnoses (other than alcohol and nicotine dependence for the AD group and nicotine dependence for the HC group); lifetime history of head injury with loss of consciousness over 5 minutes; neurological disorders; low level of education (school drop-out before age 16); use of medication affecting the central nervous system; positive urine tests for alcohol or drug use prior to MRI imaging.
fMRI: effective connectivity analyses
To assess connectivity between brain regions during decision making in the delay discounting task that interacted with modafinil administration, we used a generalized form of PsychoPhysiological Interaction analyses (gPPI; McLaren et al. 2012) . For each subject, volumes of interest were extracted and used as seeds in single-subject whole-brain PPI analyses. Seed regions were chosen based on the main findings in the second level analyses and were defined as 5 mm radius spheres around peak voxel coordinates of activation clusters. For each subject and each seed region, the physiological activity of the seed region was computed as the mean time series of all voxels within a 5 mm radius sphere centered at the peak activation coordinate obtained in the group analyses. An estimate of the underlying neuronal activity that produced the physiological activity in the seed region was computed by deconvolving the BOLD signal (Gitelman et al. 2003) . Next, PPI regressors were generated by multiplying the estimated neuronal activity from the seed region with a vector coding for effects of each task condition. For every seed region, first level statistical analyses were performed by generating and estimating a model involving for each session (placebo and modafinil): the PPI regressors of each task condition (convolved with the canonical HRF), the psychological regressors corresponding to each task regressor from the original first level design, the physiological activity from the seed region and a constant term. Based on the results of the GLM second level analyses, one PPI contrast was created for (immediate choices: modafinil>placebo) to identify modafinil induced functional connectivity changes of the seed region with other regions in the brain during choices for the immediate reward. Subsequently, a second-level random effects analysis was performed on these contrast images. Results are reported at a corrected significance level of p<0.05 within the ROIs using a small volume correction (SVC) or across the entire brain. 
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Supplementary Tables
Supplementary Figures
Figure S1: Main effect of task Activation during the selection of immediate rewards (top) and during the selection of delayed rewards (bottom). The figure shows activation in visual processing areas, executive control areas and reward-related areas (including limbic regions). Deactivation was found in the ventromedial prefrontal cortex and posterior cingulate cortex (in blue). All activations are displayed at whole brain voxel wise p<0.05 FWE corrected.
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